Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class o...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.12.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates generally to anti-angiogenesis agents and related methods of using to anti-angiogenesis agents for biomedical applications including direct monotherapy and combination therapy for treatment of an angiogenesis related condition. In an embodiment, the invention provides a class of opioid compounds and structurally related opioid derivatives exhibiting anti-VEGF activity for use in therapeutic procedures, including phototherapy. Opioid compounds and structurally related opioid derivatives of the invention may be administered alone or in combination with administration of a phototherapy agent and/or other therapeutic agent. |
---|---|
Bibliography: | Application Number: US201414316415 |